b3c newswire Press Releases - EIN Presswire - Press Release Distribution Service

Published on November 7, 2019 - 10:21 GMT

SOTIO Exercises Second Target Option Under Existing Collaboration with NBE-Therapeutics to Develop Next-Generation Antibody-Drug ...

BASEL, Switzerland and PRAGUE, Czech Republic , November 07, 2019 / B3C newswire / -- NBE-Therapeutics AG and SOTIO a.s. today announced that SOTIO has elected a second target for the development of a next generation antibody-drug conjugate (ADC) under …

Distribution channels: Technology

Published on November 5, 2019 - 08:32 GMT

SciRhom Initiates First-In-Class Antibody Development Program to Treat Major Autoimmune Diseases

Bench to bedside research provides a new business opportunity: Newly discovered antibodies against iRhom2 block several pro-inflammatory pathways simultaneously, promising significant improvement over current autoimmune therapies. MUNICH, Germany, November …

Distribution channels: Technology

Published on November 4, 2019 - 13:24 GMT

Ichnos Sciences Announces Completion of Enrollment of Phase 2b Trials for Two Investigational Therapies - ISB 830 And ISC 27864

PARAMUS, NJ, USA, November 04, 2019 / B3C newswire / -- Ichnos (‘īk-nōz) Sciences today announced that it has completed enrollment of two Phase 2b clinical trials for two candidates in clinical development: ISB 830, an OX40 antagonist monoclonal antibody …

Distribution channels: Technology

Published on October 30, 2019 - 16:33 GMT

Vetter Provides Greater Flexibility in Secondary Packaging Through Collaborative Work

The CDMO increasingly relies on close interaction of humans and machines Successful implementation of collaborative dual-arm robot YuMi Innovative response to rising customer demands for greater flexibility Acquisition of more robots planned RAVENSBURG, …

Distribution channels: Technology

Published on October 30, 2019 - 13:07 GMT

SeraNovo Enters into License Agreement with Carna Biosciences for Development of Oral Formulation of Carna's Kinase Inhibitor

LEIDEN, the Netherlands, October 30, 2019 / B3C newswire / -- SeraNovo B.V. today announced that it has signed a License Agreement with Carna Biosciences, Inc., a company engaged in drug development specializing in the development of kinase inhibitors. …

Distribution channels: Technology

Published on October 30, 2019 - 08:24 GMT

TSI Reports Enrollment of First 10 Patients in its Phase 2 Ischemic Stroke Clinical Trial and Completion of its Phase 2 Study ...

Studies Aim to Confirm Safety and Efficacy of Novel Bio-inspired Clot-dissolving Therapy CAMBRIDGE, Mass, USA October 30, 2019 / B3C newswire / -- Thrombolytic Science, LLC (TSI) today announced progress with 10 patients enrolled in its prospective, …

Distribution channels: Technology

Published on October 29, 2019 - 08:12 GMT

BioVersys Receives CARB-X Award of up to US$ 8.92 Million for Development of Novel Antimicrobial Therapies

For development of first-in-class stand-alone anti-virulence small molecule drugs – a paradigm shift in AMR therapy CARB-X funds BioVersys up to US$ 8.92 million to support the development of first-in-class anti-virulence small molecule drugs that disarm …

Distribution channels: Technology

Published on October 28, 2019 - 12:18 GMT

BioMed X Completes Alzheimer’s Disease Research Project

HEIDELBERG, Germany, October 28, 2019 / B3C newswire / -- BioMed X announced today the successful completion of their first research collaboration project with AbbVie in the field of tau-mediated neurodegeneration in Alzheimer’s disease. BioMed X received …

Distribution channels: Technology

Published on October 23, 2019 - 13:23 GMT

Shuwen Biotech Designated as an International Cooperation Base for Medical Diagnostic Technologies

DEQING, China, October 23, 2019 / B3C newswire / --Shuwen Biotech, a China-based leader in innovative diagnostics, announced that it has been designated as an International Cooperation Base for Novel Biomarkers and Innovative Diagnostic Technologies by …

Distribution channels: Technology

Published on October 21, 2019 - 12:22 GMT

Sartorius Stedim Biotech Launches New Sartocheck® 5 Plus Filter Tester

Highest level of data integrity as requested by regulatory authorities State-of-the-art quality risk management to comply with the upcoming EMA Annex 1 Optimal operator protection to minimize health, safety and environmental risks GOETTINGEN, Germany, …

Distribution channels: Technology

Published on October 21, 2019 - 05:16 GMT

BD Launches BD Intevia™ 1mL Two-step Disposable Autoinjector – A Robust Platform Device Combining Autoinjector and Pre-Fillable ...

New solution supports injection of different viscosities and volumes without the need for system customization GOTHENBURG, Sweden, October 21, 2019 / B3C newswire / -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology …

Distribution channels: Technology

Published on October 17, 2019 - 08:24 GMT

HepaRegeniX GmbH Announces Management Changes

Dr. Michael Lutz appointed as new CEO/Managing Director TUBINGEN, Germany, October 17, 2019 / B3C newswire / -- HepaRegeniX GmbH, a preclinical stage company developing a novel therapy for the treatment of acute and chronic liver diseases today announced …

Distribution channels: Technology

Published on October 16, 2019 - 09:04 GMT

Amarna Therapeutics Raises €10 Million to Progress Lead Development Candidate into Clinical Trials and Appoints a New Supervisory ...

Round led by Swedish investor Flerie Invest AB with substantial contributions from the Netherlands Enterprise Agency and existing shareholders Appoints a new Supervisory Board with six highly experienced individuals Start of first-in-man phase I/II …

Distribution channels: Technology

Published on October 14, 2019 - 12:19 GMT

PPF and SOTIO Invest $6.5 Million in MaveriX Oncology and its Lead Program MVX-5005

PPF Group, the majority owner of SOTIO, invests $6.5 million as part of MaveriX Oncology’s $20 million Series A financing round. SOTIO obtained an option to license and co-develop MVX-5005 in Europe. MaveriX is eligible to receive up to $138 million in …

Distribution channels: Technology

Published on October 11, 2019 - 10:24 GMT

IME Medical Electrospinning Appoints Three Seasoned Medtech and Biopharmeutical Industry Experts to its Board of Directors

Daan van den Noort MD (Chairman), Fennemiek Gommer and Jan Mellegers Appointment marks next phase in progressing IME towards a full service scientific and technical partner in Fiber-Based solutions for Medtech and Biopharmaceutical companies WAALRE, The …

Distribution channels: Technology

Published on October 10, 2019 - 07:04 GMT

Clinigen Launches Managed Access Program for Progenics Pharmaceuticals for AZEDRA® Outside the US

BURTON-ON-TRENT, England, October 10, 2019 / B3C newswire / -- Clinigen Group plc (AIM: CLIN, ‘Clinigen’), the global pharmaceutical and services company, has launched a Managed Access Program for Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX), an oncology …

Distribution channels: Technology

Published on October 8, 2019 - 09:20 GMT

NBE-Therapeutics Appoints Dr. Steffen Heeger as Chief Medical Officer for Leading The Clinical Development of NBE’s iADC Programs

BASEL, Switzerland, October 08, 2019 / B3C newswire / -- NBE-Therapeutics AG, a biopharmaceutical company developing best-in-class, immune-stimulatory antibody drug conjugates (iADCs™), today announces the appointment of Dr. Steffen Heeger as Chief Medical …

Distribution channels: Technology

Published on October 7, 2019 - 12:26 GMT

Haselmeier Signs an Exclusive Agreement with Stevanato Group to License Axis-D Pen-injector Technology and Intellectual Property ...

ZURICH, Switzerland, October 07, 2019 / B3C newswire / -- Haselmeier, a Swiss- and German-based developer and manufacturer of innovative self-injection devices, and Stevanato Group, an Italian-based producer of glass primary packaging and global leader in …

Distribution channels: Technology

Published on October 1, 2019 - 08:16 GMT

ProBioGen and Ceva Santé Animale Sign an Exclusive License Agreement to Produce Vectorised Poultry Vaccines Using AGE1.CR® ...

BERLIN, Germany and LIBOURNE, France, October 1st, 2019 / B3C newswire / -- ProBioGen AG and Ceva Santé Animale announce the signature of an exclusive license agreement for the manufacture of vectorised poultry vaccines using ProBioGen’s proprietary AGE1 …

Distribution channels: Technology

Published on October 1, 2019 - 07:49 GMT

MIMETAS and Hubrecht Organoid Technologies to Develop and Market Organoids-on-a-Chip

LEIDEN, and UTRECHT, the Netherlands, October 1st , 2019 / B3C newswire / -- MIMETAS and Hubrecht Organoid Technologies (HUB) announce that they entered into a strategic collaboration to market organoid models on a Chip. The agreement includes a license …

Distribution channels: Technology